| Literature DB >> 29681945 |
Abstract
BACKGROUND: White matter damage (WMD) is a prime risk factor for cerebral palsy, in part occurring unexplained. Though primarily a problem of preterm infants, there is growing evidence that in large newborns cephalopelvic disproportion and prolonged labor are involved.Entities:
Year: 2018 PMID: 29681945 PMCID: PMC5851296 DOI: 10.1155/2018/2120835
Source DB: PubMed Journal: Obstet Gynecol Int ISSN: 1687-9597
Various forms of white matter damage (WMD) in term-born neonates at 37–43 weeks gestation diagnosed by cranial ultrasound examination at a median of 8 days (range 1–30 days) after birth.
| # | Patient code | Lateral ventricle asymmetry | Lateral ventricle enlargement | Lateral ventricle bilateral enlargement ∗ | Posthemorrhagic hydrocephalus | Diffuse periventricular leukomalacia | Cystic periventricular leukomalacia (porencephaly) | White matter damage present |
|---|---|---|---|---|---|---|---|---|
| 1 | 28 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 2 | 34 | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| 3 | 71 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 4 | 89 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 5 | 106 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 6 | 118 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 7 | 146 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 8 | 150 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 9 | 198 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 10 | 228 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 11 | 239 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 12 | 244 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 13 | 250 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 14 | 273 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 15 | 281 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 16 | 282 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 17 | 286 | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| 18 | 295 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| 19 | 295 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 20 | 321 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 21 | 328 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 22 | 332 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 23 | 337 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 24 | 353 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 25 | 370 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 26 | 371 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 27 | 373 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 28 | 393 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 29 | 394 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 30 | 395 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 31 | 406 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 32 | 441 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 33 | 445 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 34 | 492 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 35 | 505 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 36 | 517 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 37 | 546 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 38 | 548 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 39 | 562 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 40 | 572 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 41 | 582 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 42 | 600 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 43 | 627 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 44 | 630 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 45 | 634 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| 46 | 684 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 47 | 697 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 48 | 769 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 49 | 813 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 50 | 850 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 51 | 876 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 52 | 892 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 53 | 899 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| 54 | 902 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 55 | 915 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 56 | 962 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 57 | 962 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 58 | 1,093 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 59 | 1,118 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 60 | 1,148 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| 61 | 1,445 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 1–61 | Sum | 29/61 | 57/61 | 29/61 | 3/61 | 2/61 | 0/61 | 61/61 |
| % | 48 | 93 | 48 | 5 | 3 | 0 | 100 |
1 = yes; 0 = no; ∗Bilateral enlargement of the lateral ventricle is defined as an enlargement of the lateral ventricle without ventricular asymmetry; physiologic variants of mild enlargements of lateral ventricles according to the criteria given in Materials and Methods are coded “0”.
Figure 1Illustrating cranial sonographic overlay sketch (enlarged) of (a) bilateral physiologic (symmetrical) and (b) unilateral pathologic (asymmetrical) mild enlargements of the lateral ventricles in (a) an infant at 7 weeks and (b) a newborn at 7 days of age. The sketch depicts clear criteria for (a′) physiologic variants (1 = sharp lateral angle, 2 = concave bottom, 3 = smooth inner lining, and 4 = regular echogenicity of the parenchyma in this case) and (b′) pathologic variants (1 = blunt/obtuse lateral angle, 2 = convexly shaped bottom, 3 = irregular inner lining, and 4 = asymmetry, atrophy, and porencephalic cysts as additional findings in this case) of mild enlargements of the lateral ventricle (modified illustration, [9]).
Odds ratios (OR, z-score bands) of white matter damage (WMD) assessed by cranial ultrasound according to anthropomorphic measurements in 4,725 term-born neonates at 37–43 weeks' gestation. Please note that only head circumference (HC) showed a close relation to the risk of white matter damage over all z-score bands in that the odds ratios were significantly different in the <10%, 10 to <25%, 75 to <90%, and ≥90% z-score bands as compared with the reference (25 to <75%). And also note that the morphometric index (MMI) reflects the increased risk of white matter damage <10% and ≥90% centiles and is calculated as follows: MMI = (z-scoreWeight (centile) + z-scoreLength (centile) + z-scoreHC (centile) + z-scoreWeight/Length-ratio (centile) + z-score (3.1168–0.12797∗HC (centile) + 0.0014741∗HC2 (centile)))/5.
|
| |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Measurement |
|
| <−1.28 (<10%) |
|
|
| −1.28 to <−0.67 (10 to <25%) |
|
|
| −0.67 to <0.67 (25 to <75%) |
|
| 0.67 to <1.28 (75 to <90%) |
|
|
| ≥1.28 (≥90%) |
|
|
|
| OR (CI) | OR (CI) | OR | OR (CI) | OR (CI) | |||||||||||||||||
| Weight (g) | 4,725 | 61 (1.3) | 2.96 (1.51–5.80) | 479 | 14 (2.9) |
| 1.25 (0.58–2.71) | 717 | 9 (1.3) | 0.572 | Reference | 2,284 | 23 (1.0) | 1.11 (0.48–2.60) | 772 | 7 (0.9) | 0.807 | 0.59 (0.26–1.33) | 473 | 8 (1.7) | 0.199 |
| Length (cm) | 4,725 | 61 (1.3) | 2.70 (1.16–6.28) | 257 | 8 (3.1) |
| 1.15 (0.60–2.19) | 1,413 | 19 (1.4) | 0.680 | Reference | 1,532 | 18 (1.2) | 1.28 (0.59–2.77) | 1,082 | 10 (0.9) | 0.540 | 0.86 (0.34–2.19) | 441 | 6 (1.4) | 0.754 |
| Head circumference (cm) | 4,725 | 61 (1.3) | 3.48 (1.35–8.98) | 255 | 6 (2.4) |
| 2.10 (1.09–4.04) | 1,465 | 21 (1.4) |
| Reference | 2,328 | 16 (0.7) | 0.34 (0.15–0.76) | 504 | 10 (2.0) |
| 0.14 (0.06–0.34) | 173 | 8 (4.6) |
|
| Morphometric index | 4,725 | 61 (1.3) | 0.34 (0.14–0.86) | 472 | 14 (3.0) |
| 0.00 (0.00–4.11) | 709 | 5 (0.7) | 0.412 | Reference | 2,362 | 26 (1.1) | 0.04 (0.00–39.74) | 710 | 4 (0.6) | 0.265 | 1.37 (0.29–6.34) | 472 | 12 (2.5) |
|
| Weight-length ratio ( | 4,725 | 61 (1.3) | 2.44 (1.18–5.03) | 472 | 11 (2.3) |
| 0.16 (0.78–3.32) | 708 | 11 (1.6) | 0.192 | Reference | 2,371 | 23 (1.0) | 1.03 (0.44–2.41) | 702 | 7 (1.1) | 0.949 | 0.18 (0.02–2.04) | 472 | 9 (1.9) | 0.078 |
| Ponderal index (100∗ | 4,725 | 61 (1.3) | 0.84 (0.32–2.17) | 470 | 5 (1.1) | 0.717 | 1.10 (0.54–2.27) | 714 | 10 (1.4) | 0.788 | Reference | 2,361 | 30 (1.3) | 1.10 (0.54–2.27) | 714 | 10 (1.4) | 0.788 | 1.17 (0.51–2.69) | 471 | 7 (1.5) | 0.707 |
Reference value: z-score band −0.67 to <0.67 (25th to below 75th centile); All bold p values highlight OR (CI) that are significantly different from the reference; the level of significance is given by the probability of error (p).
Figure 2Head circumference determines white matter damage (WMD) assessed by cranial ultrasound in 4,725 term-born neonates. A parabolic correlation curve was fitted to describe the relation between head circumference (HC) in centiles and the risk to develop white matter damage (%): WMD (%) = 3.1168–0.12797∗HC (centile) + 0.0014741∗HC2 (centile) (r = 0.957, p < 0.0001). Interestingly, from all growth variables at birth, only head circumference showed a close relation to the risk of white matter damage over the whole range of centiles (Table 2).
White matter damage (WMD) and obstetrical variables. Data as mean (SD) and 95% confidence intervals in morphometric index z-score bands of 4,725 term-born neonates at 37–43 weeks gestation as compared with the reference (25 to <75%).
| Morphometric index (centile) |
| Mean | SD | 95% confidence interval |
| ||
|---|---|---|---|---|---|---|---|
| Lower limit | Upper limit | ||||||
| White matter damage present | <10% | 472 | 0.03 | 0.17 | 0.01 | 0.01 | 0.001 |
| 10 to <25% | 709 | 0.01 | 0.08 | 0.00 | 0.00 | n.s. | |
| 25 to <75% | 2,362 | 0.01 | 0.10 | 0.00 | 0.01 | Reference | |
| 75 to <90% | 710 | 0.01 | 0.07 | 0.00 | 0.00 | n.s. | |
| 90 to <100% | 472 | 0.03 | 0.16 | 0.01 | 0.01 | 0.011 | |
| Total | 4,725 | 0.01 | 0.11 | 0.00 | 0.01 | ||
| EPH gestosis | <10% | 472 | 0.14 | 0.56 | 0.09 | 0.19 | <0.001 |
| 10 to <25% | 709 | 0.07 | 0.25 | 0.05 | 0.09 | n.s. | |
| 25 to <75% | 2,362 | 0.05 | 0.22 | 0.04 | 0.06 | Reference | |
| 75 to <90% | 710 | 0.06 | 0.23 | 0.04 | 0.07 | n.s. | |
| 90 to <100% | 472 | 0.11 | 0.31 | 0.08 | 0.13 | 0.001 | |
| Total | 4,725 | 0.07 | 0.29 | 0.06 | 0.08 | ||
| Twins/multiples | <10% | 472 | 0.15 | 0.35 | 0.11 | 0.18 | <0.001 |
| 10 to <25% | 709 | 0.05 | 0.21 | 0.03 | 0.06 | <0.001 | |
| 25 to <75% | 2,362 | 0.01 | 0.10 | 0.01 | 0.01 | Reference | |
| 75 to <90% | 710 | 0.00 | 0.00 | 0.00 | 0.00 | n.s. | |
| 90 to <100% | 472 | 0.00 | 0.05 | 0.00 | 0.01 | n.s. | |
| Total | 4,725 | 0.03 | 0.16 | 0.02 | 0.03 | ||
| Growth retardation (IUGR) | <10% | 472 | 0.25 | 0.43 | 0.21 | 0.28 | <0.001 |
| 10 to <25% | 709 | 0.02 | 0.14 | 0.01 | 0.03 | n.s. | |
| 25 to <75% | 2,362 | 0.00 | 0.05 | 0.00 | 0.00 | Reference | |
| 75 to <90% | 710 | 0.00 | 0.04 | 0.00 | 0.00 | n.s. | |
| 90 to <100% | 472 | 0.00 | 0.00 | 0.00 | 0.00 | n.s. | |
| Total | 4,725 | 0.03 | 0.17 | 0.02 | 0.03 | ||
| Cardiotocography, pathologic (CTG) | <10% | 472 | 0.23 | 0.42 | 0.19 | 0.26 | <0.001 |
| 10 to <25% | 709 | 0.12 | 0.32 | 0.09 | 0.14 | n.s. | |
| 25 to <75% | 2,362 | 0.09 | 0.28 | 0.07 | 0.10 | Reference | |
| 75 to <90% | 710 | 0.09 | 0.29 | 0.07 | 0.11 | n.s. | |
| 90 to <100% | 472 | 0.08 | 0.28 | 0.06 | 0.11 | n.s. | |
| Total | 4,725 | 0.11 | 0.31 | 0.10 | 0.11 | ||
| Stained amniotic fluid | <10% | 472 | 0.04 | 0.21 | 0.03 | 0.06 | n.s. |
| 10 to <25% | 708 | 0.04 | 0.18 | 0.02 | 0.05 | n.s. | |
| 25 to <75% | 2,362 | 0.04 | 0.20 | 0.04 | 0.05 | Reference | |
| 75 to <90% | 710 | 0.09 | 0.28 | 0.07 | 0.11 | <0.001 | |
| 90 to <100% | 472 | 0.07 | 0.25 | 0.04 | 0.09 | n.s. | |
| Total | 4,724 | 0.05 | 0.22 | 0.04 | 0.06 | ||
| Prolonged or obstructed labor | <10% | 472 | 0.08 | 0.27 | 0.05 | 0.10 | n.s. |
| 10 to <25% | 709 | 0.09 | 0.28 | 0.07 | 0.11 | n.s. | |
| 25 to <75% | 2,362 | 0.11 | 0.31 | 0.10 | 0.12 | Reference | |
| 75 to <90% | 710 | 0.17 | 0.38 | 0.15 | 0.20 | <0.001 | |
| 90 to <100% | 472 | 0.21 | 0.41 | 0.17 | 0.24 | <0.001 | |
| Total | 4,725 | 0.12 | 0.33 | 0.11 | 0.13 | ||
| Mode of delivery | <10% | 472 | 1.47 | 0.83 | 1.39 | 1.54 | 0.001 |
| 10 to <25% | 709 | 1.38 | 0.86 | 1.31 | 1.44 | n.s. | |
| 25 to <75% | 2,362 | 1.30 | 0.72 | 1.27 | 1.33 | Reference | |
| 75 to <90% | 710 | 1.40 | 0.79 | 1.34 | 1.45 | 0.033 | |
| 90 to <100% | 472 | 1.42 | 0.74 | 1.36 | 1.49 | 0.013 | |
| Total | 4,725 | 1.35 | 0.77 | 1.33 | 1.38 | ||
| Presentation | <10% | 471 | 1.23 | 0.64 | 1.18 | 1.29 | <0.001 |
| 10 to <25% | 708 | 1.14 | 0.51 | 1.10 | 1.18 | n.s. | |
| 25 to <75% | 2,360 | 1.10 | 0.43 | 1.08 | 1.11 | Reference | |
| 75 to <90% | 710 | 1.07 | 0.38 | 1.05 | 1.10 | n.s. | |
| 90 to <100% | 472 | 1.07 | 0.38 | 1.04 | 1.11 | n.s. | |
| Total | 4,721 | 1.11 | 0.46 | 1.10 | 1.12 | ||
| Gender | <10% | 472 | 1.60 | 0.49 | 1.55 | 1.64 | 0.013 |
| 10 to <25% | 708 | 1.57 | 0.50 | 1.53 | 1.61 | n.s. | |
| 25 to <75% | 2,358 | 1.52 | 0.50 | 1.50 | 1.54 | Reference | |
| 75 to <90% | 709 | 1.42 | 0.49 | 1.39 | 1.46 | <0.001 | |
| 90 to <100% | 472 | 1.26 | 0.45 | 1.22 | 1.30 | <0.001 | |
| Total | 4,719 | 1.49 | 0.50 | 1.48 | 1.51 | ||
Neonatal variables, Apgar scores, and acid-base balance as mean (SD) and 95% confidence intervals in morphometric index z-score bands of term-born neonates at 37–43 weeks gestation as compared with the reference (25 to <75%).
| Morphometric index (centile) |
| Mean | SD | 95% confidence interval |
| ||
|---|---|---|---|---|---|---|---|
| Lower limit | Upper limit | ||||||
| Apgar score_1′ | <10% | 471 | 8.41 | 1.38 | 8.28 | 8.53 | <0.001 |
| 10 to <25% | 709 | 8.76 | 1.10 | 8.68 | 8.84 | 0.032 | |
| 25 to <75% | 2,359 | 8.88 | 0.84 | 8.85 | 8.92 | Reference | |
| 75 to <90% | 710 | 8.85 | 0.84 | 8.79 | 8.92 | n.s. | |
| 90 to <100% | 470 | 8.79 | 0.90 | 8.70 | 8.87 | n.s. | |
| Total | 4,719 | 8.80 | 0.96 | 8.78 | 8.83 | ||
| Apgar score_5′ | <10% | 470 | 9.55 | 0.95 | 9.46 | 9.63 | <0.001 |
| 10 to <25% | 709 | 9.79 | 0.65 | 9.74 | 9.84 | 0.033 | |
| 25 to <75% | 2,358 | 9.87 | 0.50 | 9.85 | 9.89 | Reference | |
| 75 to <90% | 710 | 9.88 | 0.43 | 9.85 | 9.91 | n.s. | |
| 90 to <100% | 470 | 9.81 | 0.63 | 9.76 | 9.87 | n.s. | |
| Total | 4,717 | 9.82 | 0.59 | 9.80 | 9.84 | ||
| Apgar score_10′ | <10% | 471 | 9.83 | 0.59 | 9.78 | 9.89 | <0.001 |
| 10 to <25% | 709 | 9.94 | 0.31 | 9.92 | 9.97 | n.s. | |
| 25 to <75% | 2,360 | 9.97 | 0.23 | 9.96 | 9.98 | Reference | |
| 75 to <90% | 710 | 9.97 | 0.20 | 9.96 | 9.99 | n.s. | |
| 90 to <100% | 470 | 9.96 | 0.26 | 9.94 | 9.99 | n.s. | |
| Total | 4,720 | 9.95 | 0.30 | 9.94 | 9.96 | ||
| pH, umbilical arterial blood (UAB) | <10% | 466 | 7.27 | 0.09 | 7.26 | 7.28 | <0.001 |
| 10 to <25% | 690 | 7.28 | 0.07 | 7.28 | 7.29 | n.s. | |
| 25 to <75% | 2,318 | 7.29 | 0.07 | 7.28 | 7.29 | Reference | |
| 75 to <90% | 701 | 7.28 | 0.06 | 7.28 | 7.29 | n.s. | |
| 90 to <100% | 467 | 7.28 | 0.07 | 7.27 | 7.28 | n.s. | |
| Total | 4,642 | 7.28 | 0.07 | 7.28 | 7.28 | ||
| pCO2 (UAB) (mmHF) | <10% | 464 | 45.5 | 10.2 | 44.6 | 46.5 | n.s. |
| 10 to <25% | 688 | 44.2 | 8.2 | 43.6 | 44.8 | n.s. | |
| 25 to <75% | 2,305 | 44.6 | 8.3 | 44.2 | 44.9 | Reference | |
| 75 to <90% | 700 | 44.8 | 7.7 | 44.2 | 45.4 | n.s. | |
| 90 to <100% | 462 | 45.9 | 8.0 | 45.2 | 46.6 | 0.015 | |
| Total | 4,619 | 44.8 | 8.4 | 44.5 | 45.0 | ||
| Base excess (UAB) (mmol/ | <10% | 464 | 7.4 | 4.5 | 7.0 | 7.8 | 0.009 |
| 10 to <25% | 683 | 7.0 | 3.9 | 6.7 | 7.3 | n.s. | |
| 25 to <75% | 2,297 | 6.7 | 3.7 | 6.6 | 6.9 | Reference | |
| 75 to <90% | 696 | 7.0 | 3.9 | 6.7 | 7.3 | n.s. | |
| 90 to <100% | 459 | 6.9 | 3.9 | 6.5 | 7.2 | n.s. | |
| Total | 4,599 | 6.9 | 3.9 | 6.8 | 7.0 | ||
Weeks gestation and growth variables as mean (SD) and 95% confidence intervals in morphometric index z-score bands of 4,725 term-born neonates at 37–43 weeks' gestation as compared with the reference (25 to <75%).
| Morphometric index (centile) |
| Mean | SD | 95% confidence interval |
| ||
|---|---|---|---|---|---|---|---|
| Lower limit | Upper limit | ||||||
| Weeks gestation | <10% | 472 | 38.67 | 1.4 | 38.5 | 38.8 | <0.001 |
| 10 to <25% | 709 | 39.24 | 1.3 | 39.1 | 39.3 | <0.001 | |
| 25 to <75% | 2,362 | 40.00 | 1.1 | 40.0 | 40.0 | Reference | |
| 75 to <90% | 710 | 40.39 | 1.0 | 40.3 | 40.5 | <0.001 | |
| 90 to <100% | 472 | 40.58 | 0.9 | 40.5 | 40.7 | <0.001 | |
| Total | 4,725 | 39.87 | 1.3 | 39.8 | 39.9 | ||
| Weight (g) | <10% | 472 | 2,508 | 274 | 2,483 | 2,532 | <0.001 |
| 10 to <25% | 709 | 2,951 | 136 | 2,941 | 2,961 | <0.001 | |
| 25 to <75% | 2,362 | 3,409 | 236 | 3,400 | 3,419 | Reference | |
| 75 to <90% | 710 | 3,783 | 211 | 3,768 | 3,799 | <0.001 | |
| 90 to <100% | 472 | 4,211 | 280 | 4,186 | 4,236 | <0.001 | |
| Total | 4,725 | 3,387 | 500 | 3,372 | 3,401 | ||
| Length (cm) | <10% | 472 | 47.4 | 2.0 | 47.2 | 47.6 | <0.001 |
| 10 to <25% | 709 | 49.6 | 1.3 | 49.5 | 49.7 | <0.001 | |
| 25 to <75% | 2,362 | 51.6 | 1.6 | 51.5 | 51.6 | Reference | |
| 75 to <90% | 710 | 53.2 | 1.6 | 53.1 | 53.3 | <0.001 | |
| 90 to <100% | 472 | 54.6 | 1.8 | 54.4 | 54.8 | <0.001 | |
| Total | 4,725 | 51.4 | 2.5 | 51.3 | 51.5 | ||
| Head circumference (cm) | <10% | 472 | 32.9 | 1.3 | 32.8 | 33.1 | <0.001 |
| 10 to <25% | 709 | 33.8 | 0.8 | 33.8 | 33.9 | <0.001 | |
| 25 to <75% | 2,362 | 34.8 | 0.9 | 34.7 | 34.8 | Reference | |
| 75 to <90% | 710 | 36.1 | 0.6 | 36.1 | 36.2 | <0.001 | |
| 90 to <100% | 472 | 37.1 | 0.9 | 37.0 | 37.2 | <0.001 | |
| Total | 4,725 | 34.9 | 1.4 | 34.8 | 34.9 | ||
| Weight-length ratio ( | <10% | 472 | 52.89 | 5.07 | 52.43 | 53.34 | <0.001 |
| 10 to <25% | 709 | 59.60 | 3.32 | 59.35 | 59.84 | <0.001 | |
| 25 to <75% | 2,362 | 66.13 | 4.31 | 65.95 | 66.30 | Reference | |
| 75 to <90% | 710 | 71.16 | 4.05 | 70.87 | 71.46 | <0.001 | |
| 90 to <100% | 472 | 77.15 | 4.64 | 76.73 | 77.57 | <0.001 | |
| Total | 4,725 | 65.68 | 7.60 | 65.46 | 65.90 | ||
| PI (100∗ | <10% | 472 | 2.36 | 0.26 | 2.34 | 2.39 | <0.001 |
| 10 to <25% | 709 | 2.44 | 0.23 | 2.42 | 2.45 | <0.001 | |
| 25 to <75% | 2,362 | 2.49 | 0.23 | 2.49 | 2.50 | Reference | |
| 75 to <90% | 710 | 2.53 | 0.24 | 2.51 | 2.54 | <0.001 | |
| 90 to <100% | 472 | 2.60 | 0.24 | 2.58 | 2.62 | <0.001 | |
| Total | 4,725 | 2.49 | 0.24 | 2.48 | 2.49 | ||